NCT00345761 - Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

July 31, 2010

Conditions

Colorectal Cancer

Interventions

DRUG

Bevacizumab

7.5 mg/kg(i.v.) on Day 1 of 1 cycle(3 weeks)

DRUG

Oxaliplatin

130 mg/m2(i.v.) on Day 1 of 1 cycle(3 weeks)

DRUG

Capecitabine

2000 mg/m2/day(p.o.) for 14 days in 1 cycle(3 weeks)

Trial Locations (4)

Hokkaido Region, Hokkaido

Kanto Region, Kanto

Kinki Region, Kinki

Tokai Region, Tōkai